Form D — Vimy Pharmaceuticals Inc.
0001493152-26-046867 · filed Oct 13, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $1,010,798
- Total sold
- $1,010,798
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Vimy Pharmaceuticals Inc.
- CIK
- 2159983
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- 2024
- Address
- 2 BLOOR STREET WEST
TORONTO, A6 M4W1J5 - Phone
- 416-254-4774
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David John Suchon · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Farris Smith · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Darryl Firsten · DirectorToronto, A6 Find on LinkedIn ↗
-
Riccardo Trecroce · DirectorToronto, A6 Find on LinkedIn ↗
-
Christopher Burkett · DirectorToronto, A6 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗